Denis Vujičić, managing director of MSD Poland, discusses his overriding mission to give Polish patients greater access to breakthrough therapies and highlights the affiliate’s extensive R&D capabilities that entail both domestic and global operations. Furthermore, he highlights the important steps that MSD is undertaking to strengthen its position as the premier partner of choice for all key stakeholders involved in the Polish healthcare ecosystem and his future aspirations as he grows into his role.
As the recently appointed manging director of MSD Poland, what are your main objectives since taking up the role?
"As the premier research based company in the world, we are strongly committed to remain at the forefront of the Polish innovative landscape."
